Efficacy and Safety Study of Biweekly Docetaxel and DeGramont Regimen in First-Line Treatment of Unresectable or Metastatic Gastric Adenocarcinoma (DaeMon)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2012 by Sixth Affiliated Hospital, Sun Yat-sen University.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Jian Xiao, Sixth Affiliated Hospital, Sun Yat-sen University
ClinicalTrials.gov Identifier:
NCT01567618
First received: March 27, 2012
Last updated: March 28, 2012
Last verified: March 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2014
  Estimated Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)